Brain Low-risk Aneurysm Stereotactic Radiosurgical Trial
BLAST
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to confirm the feasibility and safety of performing radiosurgery on unruptured, low-risk aneurysms in humans. Participants will choose if they want to undergo radiosurgery or not. Participants who choose not to have radiosurgery will be assigned to the observational group. Participants who choose to have radiosurgery performed will be assigned to the radiosurgery group. Participants in both groups will attend an initial exam session as well as four follow-up sessions: Day 0
- Initial questionnaire
- CTA scan
- MRI
- Radiosurgery performed on patients in the radiosurgery group 6 months
- CTA scan
- Follow-up questionnaire 12 months
- CTA scan
- MRI
- Follow-up questionnaire 24 months
- CTA scan
- Follow-up questionnaire 36 months
- CTA scan
- MRI
- Follow-up questionnaire Researchers will compare the observational group and the radiosurgery group to see if there is a difference in the incidence of aneurysm rupture during the study period (3 years). The hypothesis is that radiosurgery should not increase the risk of aneurysm rupture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
February 14, 2025
February 1, 2025
5 years
September 15, 2023
February 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Between group difference in the incidence of aneurysm rupture during the study period
The hypothesis is that SRS should not increase this risk.
3 years from SRS
Secondary Outcomes (5)
Incidence of any radiation-induced complications
3 years
Incidence of endovascular or surgical aneurysm treatment during the latency period
3 years
Change in aneurysm volume relative to baseline
3 years
Change in aneurysm shape indices relative to baseline
3 years
Aneurysm occlusion confirmed by CT-angiography (CTA)
at 3 years from SRS
Study Arms (2)
SRS group
EXPERIMENTALParticipants in the SRS group will receive the intervention described earlier, consisting of a Gamma Knife radiosurgery, and undergo the same follow-up exams (radiological and clinical) as participants of the control group.
Control group
NO INTERVENTIONThe medical care will consist of observation for any element that may indicate an increased risk of rupture, like aneurysm growth or instability in shape.
Interventions
All treatments will be performed using the Gamma Knife Perfexion or Icon system (Elekta). The following treatment parameters will be used: * The head will be immobilized using a stereotactic Leksell Model G frame, installed using local protocols * Targeting will be performed by using a stereotactic CTA. No MRI will be performed. * Only one aneurysm will be treated per patient * The aneurysm, including its neck, will be contoured and targeted using a combination of 4mm isocenters as deemed appropriate by the treating team * A prescription dose of 25 Gy at the margin of the target will be used * The maximal dose on optic pathways will be kept below 10 Gy * The brainstem 12-Gy volume will be kept below 1cc
Eligibility Criteria
You may qualify if:
- Medical imaging (CTA, MRA or digital substraction angiography) reveals the existence of an asymptomatic unruptured saccular anterior circulation intracranial aneurysm under 7 mm
- Advised by a vascular neurosurgeon to observe rather than undergo endovascular or microsurgical management
You may not qualify if:
- Prior history of aneurysmal rupture
- Presence of symptoms that could be attributed to the aneurysm (severe headache, third cranial nerve deficits, or others)
- Imaging features deemed to increase rupture risk as evaluated by the treating physician
- Posterior circulation aneurysm
- Fusiform aneurysm
- Dissecting aneurysm
- Mycotic aneurysm
- Direct contact between the aneurysm and the optic pathways on medical imaging
- Prior coils or clips in the targeted aneurysm or any other aneurysm
- Patient unable to consent
- Patient unable or unlikely to comply with the follow-up schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr David Mathieulead
- Université de Sherbrookecollaborator
- Centre de recherche du Centre hospitalier universitaire de Sherbrookecollaborator
Study Sites (1)
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
Related Publications (25)
Kleinloog R, de Mul N, Verweij BH, Post JA, Rinkel GJE, Ruigrok YM. Risk Factors for Intracranial Aneurysm Rupture: A Systematic Review. Neurosurgery. 2018 Apr 1;82(4):431-440. doi: 10.1093/neuros/nyx238.
PMID: 28498930BACKGROUNDBonneville F, Sourour N, Biondi A. Intracranial aneurysms: an overview. Neuroimaging Clin N Am. 2006 Aug;16(3):371-82, vii. doi: 10.1016/j.nic.2006.05.001.
PMID: 16935705BACKGROUNDMeadowcroft MD, Cooper TK, Rupprecht S, Wright TC, Neely EE, Ferenci M, Kang W, Yang QX, Harbaugh RE, Connor JR, McInerney J. Gamma Knife radiosurgery of saccular aneurysms in a rabbit model. J Neurosurg. 2018 Dec 1;129(6):1530-1540. doi: 10.3171/2017.6.JNS17722. Epub 2018 Jan 12.
PMID: 29328001BACKGROUNDErratum: Management of unruptured intracranial aneurysms. Neurol Clin Pract. 2014 Apr;4(2):98. doi: 10.1212/CPJ.0000000000000019.
PMID: 29443238BACKGROUNDFlemming KD, Lanzino G. Management of Unruptured Intracranial Aneurysms and Cerebrovascular Malformations. Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):181-210. doi: 10.1212/CON.0000000000000418.
PMID: 28157750BACKGROUNDSchievink WI. Intracranial aneurysms. N Engl J Med. 1997 Jan 2;336(1):28-40. doi: 10.1056/NEJM199701023360106. No abstract available.
PMID: 8970938BACKGROUNDFusco MR, Ogilvy CS. Surgical and endovascular management of cerebral aneurysms. Int Anesthesiol Clin. 2015 Winter;53(1):146-65. doi: 10.1097/AIA.0000000000000038. No abstract available.
PMID: 25551747BACKGROUNDBrown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 2014 Apr;13(4):393-404. doi: 10.1016/S1474-4422(14)70015-8.
PMID: 24646873BACKGROUNDBurns JD, Brown RD Jr. Treatment of unruptured intracranial aneurysms: surgery, coiling, or nothing? Curr Neurol Neurosci Rep. 2009 Jan;9(1):6-12. doi: 10.1007/s11910-009-0002-0.
PMID: 19080747BACKGROUNDTruelsen T, Bonita R, Duncan J, Anderson NE, Mee E. Changes in subarachnoid hemorrhage mortality, incidence, and case fatality in New Zealand between 1981-1983 and 1991-1993. Stroke. 1998 Nov;29(11):2298-303. doi: 10.1161/01.str.29.11.2298.
PMID: 9804637BACKGROUNDQureshi AI, Suri MF, Nasar A, Kirmani JF, Divani AA, He W, Hopkins LN. Trends in hospitalization and mortality for subarachnoid hemorrhage and unruptured aneurysms in the United States. Neurosurgery. 2005 Jul;57(1):1-8; discussion 1-8. doi: 10.1227/01.neu.0000163081.55025.cd.
PMID: 15987534BACKGROUNDBrisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006 Aug 31;355(9):928-39. doi: 10.1056/NEJMra052760. No abstract available.
PMID: 16943405BACKGROUNDMolyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005 Sep 3-9;366(9488):809-17. doi: 10.1016/S0140-6736(05)67214-5.
PMID: 16139655BACKGROUNDWiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003 Jul 12;362(9378):103-10. doi: 10.1016/s0140-6736(03)13860-3.
PMID: 12867109BACKGROUNDFroelich JJ, Neilson S, Peters-Wilke J, Dubey A, Thani N, Erasmus A, Carr MW, Hunn AW. Size and Location of Ruptured Intracranial Aneurysms: A 5-Year Clinical Survey. World Neurosurg. 2016 Jul;91:260-5. doi: 10.1016/j.wneu.2016.04.044. Epub 2016 Apr 20.
PMID: 27108026BACKGROUNDStarke RM, Kano H, Ding D, Lee JY, Mathieu D, Whitesell J, Pierce JT, Huang PP, Kondziolka D, Yen CP, Feliciano C, Rodgriguez-Mercado R, Almodovar L, Pieper DR, Grills IS, Silva D, Abbassy M, Missios S, Barnett GH, Lunsford LD, Sheehan JP. Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort. J Neurosurg. 2017 Jan;126(1):36-44. doi: 10.3171/2015.9.JNS151311. Epub 2016 Mar 4.
PMID: 26943847BACKGROUNDKim BS, Kim KH, Lee MH, Lee JI. Stereotactic Radiosurgery for Brainstem Cavernous Malformations: An Updated Systematic Review and Meta-Analysis. World Neurosurg. 2019 Oct;130:e648-e659. doi: 10.1016/j.wneu.2019.06.183. Epub 2019 Jul 2.
PMID: 31276856BACKGROUNDGrady C, Gesteira Benjamin C, Kondziolka D. Radiosurgery for dural arteriovenous malformations. Handb Clin Neurol. 2017;143:125-131. doi: 10.1016/B978-0-444-63640-9.00012-6.
PMID: 28552134BACKGROUNDSchneider BF, Eberhard DA, Steiner LE. Histopathology of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg. 1997 Sep;87(3):352-7. doi: 10.3171/jns.1997.87.3.0352.
PMID: 9285598BACKGROUNDLan Z, Li J, You C, Chen J. Successful use of Gamma Knife surgery in a distal lenticulostriate artery aneurysm intervention. Br J Neurosurg. 2012 Feb;26(1):89-90. doi: 10.3109/02688697.2011.591949. Epub 2011 Jul 18.
PMID: 21767129BACKGROUNDLiscak R, Vymazal J, Chytka T. Gamma Knife Radiosurgery of Distal Aneurysm: A Case Series. Stereotact Funct Neurosurg. 2021;99(5):381-386. doi: 10.1159/000513956. Epub 2021 Mar 17.
PMID: 33730736BACKGROUNDRaghavan ML, Ma B, Harbaugh RE. Quantified aneurysm shape and rupture risk. J Neurosurg. 2005 Feb;102(2):355-62. doi: 10.3171/jns.2005.102.2.0355.
PMID: 15739566BACKGROUNDDing D, Xu Z, Starke RM, Yen CP, Shih HH, Buell TJ, Sheehan JP. Radiosurgery for Cerebral Arteriovenous Malformations with Associated Arterial Aneurysms. World Neurosurg. 2016 Mar;87:77-90. doi: 10.1016/j.wneu.2015.11.080. Epub 2015 Dec 28.
PMID: 26732956BACKGROUNDKim M, Pyo S, Jeong Y, Lee S, Jung Y, Jeong H. Gamma Knife surgery for intracranial aneurysms associated with arteriovenous malformations. J Neurosurg. 2006 Dec;105 Suppl:229-34. doi: 10.3171/sup.2006.105.7.229.
PMID: 18503361BACKGROUNDVymazal J, Liscak R, Novotny J Jr, Janouskova L, Vladyka V. The role of Gamma Knife radiosurgery in arteriovenous malformation with aneurysms. Stereotact Funct Neurosurg. 1999;72 Suppl 1:175-84. doi: 10.1159/000056454.
PMID: 10681706BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Mathieu, MD FRCS(C)
Service de neurochirurgie, Département de chirurgie, Centre hospitalier universitaire de Sherbrooke
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of the Division of Neurosurgery
Study Record Dates
First Submitted
September 15, 2023
First Posted
September 21, 2023
Study Start
June 1, 2025
Primary Completion (Estimated)
June 1, 2030
Study Completion (Estimated)
June 1, 2030
Last Updated
February 14, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
No individual participant data will be made available to other researchers.